CoChat

Glucagon-Like Peptide-1-(7-36)Amide Increases Pulmonary Surfactant Secretion through a Cyclic Adenosine 3',5'-Monophosphate-Dependent Protein Kinase Mechanism in Rat Type II Pneumocytes

Open access
Enrique Benito, Enrique Blázquez, María A. Bosch · 1998 · Endocrinology
Cited by 45

The DOI matches its OpenAlex record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Glucagon-like peptide-1 (GLP-1) receptor messenger RNA has been identified in cells considered type II pneumocytes that are involved in the synthesis and secretion of the pulmonary surfactant. In an attempt to open new insights into the control of surfactant secretion, we studied the effects of glucagon-related peptides in this process. Accordingly, type II pneumocytes were isolated from Wistar rat lungs and cultured overnight with [methyl-14C]choline, and then the basal and stimulated secretions of [14C]phosphatidylcholine were measured. GLP-1(7-36)amide stimulated phosphatidylcholine secretion in a concentration-dependent manner in the 1-100 nM range; the concentration of the peptide that produced a half-maximal response was 10 nM. Exendin-4 induced similar effects. No changes were observed when GLP-1-(1-37), GLP-2, or exendin-(9-39) was added to the medium. However, the latter reversed the stimulatory effects of GLP-1-(7-36)amide and exendin-4. A study of the mechanism through which GLP-1-(7-36)amide exerts its stimulatory effect was carried out using different agents that are well known stimulants of phosphatidylcholine secretion. GLP-1-(7-36)amide did not produce any change in the stimulatory effect observed with terbutaline or 8-bromo-cAMP, suggesting the involvement of a cAMP-dependent protein kinase in the stimulatory effect of this peptide on phosphatidylcholine secretion. It was further supported by the use of inhibitors of protein kinases and by the stimulation of cAMP production in type II pneumocytes incubated with either GLP-1-(7-36)amide or exendin-4.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

OpenAlex · 10.1210/en.139.5.2363

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 38

  1. Hoosein, 1984, Human glucagon-like peptides 1 and 2 activate rat brain adenylate cyclase., FEBS Lett, 178, 83, 10.1016/0014-5793(84)81245-4 · DOI · Paper page
  2. Drucker, 1996, Induction of intestinal epithelial proliferation by glucagon-like peptide 2., Proc Natl Acad Sci USA, 93, 7911, 10.1073/pnas.93.15.7911 · DOI · Paper page
  3. Thorens, 1993, Cloning and functional expression of the human islet GLP-1 receptor., Diabetes, 42, 1678, 10.2337/diab.42.11.1678 · DOI · Paper page
  4. Dillon, 1993, Cloning and functional expression of the human glucagon-like peptide-1 (GLP-1) receptor., Endocrinology, 133, 1907, 10.1210/endo.133.4.8404634 · doi:10.1210/endo.133.4.8404634 · Paper page
  5. Alvarez, 1996, Expression of the glucagon-like peptide-1 receptor gene in rat brain., J Neurochem, 66, 920, 10.1046/j.1471-4159.1996.66030920.x · DOI · Paper page
  6. Göke, 1989, Characterization of the receptor for glucagon-like peptide-1 (7–36)amide on plasma membranes from rat insulinoma-derived cells by covalent cross-linking., J Mol Endocrinol, 2, 93, 10.1677/jme.0.0020093 · DOI · Paper page
  7. Gros, 1993, Glucagon-like peptide-1 (7–36)amide, oxyntomodulin and glucagon interact with a common receptor in a somastostatin-secreting cell line., Endocrinology, 133, 631, 10.1210/endo.133.2.8102095 · DOI · Paper page
  8. Utthenthal, 1990, Characterization of high-affinity receptors for truncated glucagon-like peptide-1 in rat gastric glands., FEBS Lett, 262, 139, 10.1016/0014-5793(90)80173-G · DOI · Paper page
  9. Valverde, 1993, Presence and characterization of glucagon-like peptide-1 (7–36)amide receptors in solubilized membranes of rat adipose tissue., Endocrinology, 132, 75, 10.1210/endo.132.1.8380388 · doi:10.1210/endo.132.1.8380388 · Paper page
  10. Richter, 1991, Characterization of glucagon-like peptide-1 (7–36)amide receptors of rat lung membranes by covalent cross-linking., FEBS Lett, 280, 247, 10.1016/0014-5793(91)80303-K · DOI
  11. Shimizu, 1987, Identification and localization of glucagon-like peptide-1 and its receptor in rat brain., Endocrinology, 121, 1076, 10.1210/endo-121-3-1076 · DOI · Paper page
  12. Kanse, 1988, Identification and characterization of glucagon-like peptide-1 (7–36)amide-binding sites in the rat brain and lung., FEBS Lett, 241, 209, 10.1016/0014-5793(88)81063-9 · DOI · Paper page
  13. Uttenthal, 1992, Autoradiographic localization of receptors for glucagon-like peptide-1 (7–36)amide in rat brain., Neuropeptides, 21, 143, 10.1016/0143-4179(92)90036-V · DOI
  14. Calvo, 1995, Structural characterization by affinity cross-linking of glucagon-like peptide-1 (7–36)amide receptor in rat brain., J Neurochem, 64, 299, 10.1046/j.1471-4159.1995.64010299.x · DOI · Paper page
  15. Mojsov, 1987, Insulinotropin: glucagon-like peptide-1 (7–37)co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas., J Clin Invest, 79, 616, 10.1172/JCI112855 · DOI · Paper page
  16. Kreymann, 1987, Glucagon-like peptide-1 (7–36): a physiological incretin in man., Lancet, 2, 1300, 10.1016/S0140-6736(87)91194-9 · DOI · Paper page
  17. Schmid, 1990, Comparison of GLP-1 (7–36)amide and GIP on release of somatostatin-like immunoreactivity and insulin from the isolated rat pancreas., Z Gastroenterol, 28, 280
  18. Schjoldeger, 1989, GLP-1 (glucagon-like peptide-1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in man., Dig Dis Sci, 35, 703, 10.1007/BF01540341 · DOI · Paper page
  19. Layer, 1996, Glucagon-like peptide-1 (GLP-1) inhibits pancreatic enzyme secretion in humans, Gastroenterology, 110, F1409
  20. Orskov, 1995, Is the effect of glucagon-like peptide-1 on gastric emptying centrally mediated?, Diabetologia, 38, A39
  21. Lambert, 1994, A role for GLP-1 (7–36)NH2 in the central control of feeding behavior., Digestion, 54, 360
  22. Navarro, 1996, Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake., J Neurochem, 67, 1982, 10.1046/j.1471-4159.1996.67051982.x · DOI · Paper page
  23. O′shea, 1996, A role for central glucagon-like peptide-1 in temperature regulation., Neuroreport, 7, 830, 10.1097/00001756-199602290-00035 · DOI · Paper page
  24. Barragán, 1994, Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1 (7–36)amide in rats, Am J Physiol, 266, E459
  25. Barragán, 1996, Interactions of exendin-(9–39) with the effects of glucagon-like peptide-1-(7–36)amide and of exendin-4 on arterial blood pressure and heart rate in rats., Regul Pept, 67, 63, 10.1016/S0167-0115(96)00113-9 · DOI
  26. Richter, 1993, GLP-1 stimulates secretion of macromolecules from airways and relaxes pulmonary artery, Am J Physiol, 265, L374
  27. Bullock, 1996, Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor., Endocrinology, 137, 2968, 10.1210/endo.137.7.8770921 · DOI · Paper page
  28. Wright, 1987, Metabolism and turnover of lung surfactant., Am Rev Respir Dis, 136, 426, 10.1164/ajrccm/136.2.426 · DOI
  29. Rooney, 1994, Molecular and cellular processing of lung surfactant., FASEB J, 8, 957, 10.1096/fasebj.8.12.8088461 · DOI · Paper page
  30. Aracil, 1985, Influence of E. coli lipopolysaccharide binding to rat alveolar type II cells on their functional properties., Mol Cell Biochem, 68, 59, 10.1007/BF00219389 · DOI
  31. Dobbs, 1986, An improved method for isolating type II cells in high yield and purity., Am Rev Respir Dis, 138, 1268
  32. Edelson, 1988, Alkaline phosphatase: a marker of alveolar type II cell diferentiation., Am Rev Respir Dis, 138, 1268, 10.1164/ajrccm/138.5.1268 · DOI · Paper page
  33. Bendford, 1987, Biochemical Toxicology: A Practical Approach, 57
  34. Rauffman, 1992, Truncated glucagon-like peptide-1 interacts with exendin receptors on dispersed acini from guinea pig pancreas. Identification of a mammalian analogue of the reptilian peptide exendin-4., J Biol Chem, 267, 21432, 10.1016/S0021-9258(19)36628-1 · DOI · Paper page
  35. Göke, 1993, Exendin-4 is a high potency agonist and truncated exendin-(9–39)amide an antagonist at the glucagon-like peptide-1-(7–36)amide receptor of insulin-secreting β-cells., J Biol Chem, 268, 19650, 10.1016/S0021-9258(19)36565-2 · DOI · Paper page
  36. Rice, 1985, Activation of cAMP dependent protein kinase during surfactant release from type II pneumocytes., Exp Lung Res, 9, 135, 10.3109/01902148509061533 · DOI
  37. Lankat-Buttgereir, 1994, Molecular cloning of a DNA encoding the GLP-1 receptors expressed in rat lung., Exp Clin Endocrinol, 102, 341, 10.1055/s-0029-1211301 · DOI · Paper page
  38. Campos, 1994, Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse., Endocrinology, 134, 2156, 10.1210/endo.134.5.8156917 · doi:10.1210/endo.134.5.8156917 · Paper page

Cited by

See all 45

Metadata

Authors
Benito, E., Blázquez, E., & Bosch, M. A.
Venue
Endocrinology
Published
1998-05-01
Volume
139
Issue
5
Pages
2363-2368
ISSN
  • 0013-7227 (ISSN-L)
  • 1945-7170
OpenAlex
W2109887220
Cited by
45
References
6
FWCI
3.31
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glucagon-Like Peptide-1-(7-36)Amide Increases Pulmonary Surfactant Secretion through a Cyclic Adenosine 3',5'-Monophosphate-Dependent Protein Kinase Mechanism in Rat Type II Pneumocytes. https://app.cochat.ai/papers/10.1210/en.139.5.2363
The paper
Benito, E., Blázquez, E., & Bosch, M. A. (1998). Glucagon-Like Peptide-1-(7-36)Amide Increases Pulmonary Surfactant Secretion through a Cyclic Adenosine 3',5'-Monophosphate-Dependent Protein Kinase Mechanism in Rat Type II Pneumocytes. Endocrinology. https://doi.org/10.1210/en.139.5.2363

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.